BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 20584868)

  • 21. Lipoprotein(a) catabolism: a case of multiple receptors.
    McCormick SPA; Schneider WJ
    Pathology; 2019 Feb; 51(2):155-164. PubMed ID: 30595508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein(a).
    Tsimikas S; Duff GW; Berger PB; Rogus J; Huttner K; Clopton P; Brilakis E; Kornman KS; Witztum JL
    J Am Coll Cardiol; 2014 May; 63(17):1724-34. PubMed ID: 24530664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute impact of apheresis on oxidized phospholipids in patients with familial hypercholesterolemia.
    Arai K; Orsoni A; Mallat Z; Tedgui A; Witztum JL; Bruckert E; Tselepis AD; Chapman MJ; Tsimikas S
    J Lipid Res; 2012 Aug; 53(8):1670-8. PubMed ID: 22628616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice.
    Que X; Hung MY; Yeang C; Gonen A; Prohaska TA; Sun X; Diehl C; Määttä A; Gaddis DE; Bowden K; Pattison J; MacDonald JG; Ylä-Herttuala S; Mellon PL; Hedrick CC; Ley K; Miller YI; Glass CK; Peterson KL; Binder CJ; Tsimikas S; Witztum JL
    Nature; 2018 Jun; 558(7709):301-306. PubMed ID: 29875409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease.
    Tsimikas S; Brilakis ES; Miller ER; McConnell JP; Lennon RJ; Kornman KS; Witztum JL; Berger PB
    N Engl J Med; 2005 Jul; 353(1):46-57. PubMed ID: 16000355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidized Phospholipids and Risk of Calcific Aortic Valve Disease: The Copenhagen General Population Study.
    Kamstrup PR; Hung MY; Witztum JL; Tsimikas S; Nordestgaard BG
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1570-1578. PubMed ID: 28572160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The binding of animal low-density lipoproteins to human apolipoprotein(a).
    Trieu VN; McConathy WJ
    Biochem J; 1995 Aug; 309 ( Pt 3)(Pt 3):899-904. PubMed ID: 7639708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
    Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a).
    Leibundgut G; Scipione C; Yin H; Schneider M; Boffa MB; Green S; Yang X; Dennis E; Witztum JL; Koschinsky ML; Tsimikas S
    J Lipid Res; 2013 Oct; 54(10):2815-30. PubMed ID: 23828779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantification of apo[a] and apoB in human atherosclerotic lesions.
    Pepin JM; O'Neil JA; Hoff HF
    J Lipid Res; 1991 Feb; 32(2):317-27. PubMed ID: 1829751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. OxPL/apoB, lipoprotein(a) and OxLDL biomarkers and cardiovascular disease in chronic hemodialysis patients.
    Bossola M; Tazza L; Luciani G; Tortorelli A; Tsimikas S
    J Nephrol; 2011; 24(5):581-8. PubMed ID: 21404224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis.
    Zheng KH; Tsimikas S; Pawade T; Kroon J; Jenkins WSA; Doris MK; White AC; Timmers NKLM; Hjortnaes J; Rogers MA; Aikawa E; Arsenault BJ; Witztum JL; Newby DE; Koschinsky ML; Fayad ZA; Stroes ESG; Boekholdt SM; Dweck MR
    J Am Coll Cardiol; 2019 May; 73(17):2150-2162. PubMed ID: 31047003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis.
    Capoulade R; Chan KL; Yeang C; Mathieu P; Bossé Y; Dumesnil JG; Tam JW; Teo KK; Mahmut A; Yang X; Witztum JL; Arsenault BJ; Després JP; Pibarot P; Tsimikas S
    J Am Coll Cardiol; 2015 Sep; 66(11):1236-1246. PubMed ID: 26361154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monocyte subset distribution in patients with stable atherosclerosis and elevated levels of lipoprotein(a).
    Krychtiuk KA; Kastl SP; Hofbauer SL; Wonnerth A; Goliasch G; Ozsvar-Kozma M; Katsaros KM; Maurer G; Huber K; Dostal E; Binder CJ; Pfaffenberger S; Oravec S; Wojta J; Speidl WS
    J Clin Lipidol; 2015; 9(4):533-41. PubMed ID: 26228671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease.
    Tsimikas S; Tsironis LD; Tselepis AD
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2094-9. PubMed ID: 17626905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxidized phospholipids are present on plasminogen, affect fibrinolysis, and increase following acute myocardial infarction.
    Leibundgut G; Arai K; Orsoni A; Yin H; Scipione C; Miller ER; Koschinsky ML; Chapman MJ; Witztum JL; Tsimikas S
    J Am Coll Cardiol; 2012 Apr; 59(16):1426-37. PubMed ID: 22497821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of apolipoprotein M in uremic atherosclerosis.
    Bosteen MH; Madsen Svarrer EM; Bisgaard LS; Martinussen T; Madsen M; Nielsen LB; Christoffersen C; Pedersen TX
    Atherosclerosis; 2017 Oct; 265():93-101. PubMed ID: 28866363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxidation-specific biomarkers and risk of peripheral artery disease.
    Bertoia ML; Pai JK; Lee JH; Taleb A; Joosten MM; Mittleman MA; Yang X; Witztum JL; Rimm EB; Tsimikas S; Mukamal KJ
    J Am Coll Cardiol; 2013 May; 61(21):2169-79. PubMed ID: 23541965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of oxidized phospholipids, lipoprotein (a) and biomarkers of oxidized lipoproteins in chronically occluded coronary arteries in sudden cardiac death and following successful percutaneous revascularization.
    Fefer P; Tsimikas S; Segev A; Sparkes J; Otsuka F; Kolodgie F; Virmani R; Juliano J; Charron T; Strauss BH
    Cardiovasc Revasc Med; 2012; 13(1):11-9. PubMed ID: 22079685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lp(a)-Associated Oxidized Phospholipids in Healthy Black and White Participants in Relation to apo(a) Size, Age, and Family Structure.
    Berglund L; Kim K; Zhang W; Prakash N; Truax K; Anuurad E; Enkhmaa B
    J Am Heart Assoc; 2021 Sep; 10(17):e020158. PubMed ID: 34431330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.